Practical Guide to Hereditary Breast and Ovarian Cancer II : Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2022 / Sakurai, Akihiro (EDT)/ Yamauchi, Hideko (EDT)/ Okamoto, Aikou (EDT)

ホーム
> 洋書
> 英文書
> Medical

Practical Guide to Hereditary Breast and Ovarian Cancer II : Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2022

個数：

Practical Guide to Hereditary Breast and Ovarian Cancer II : Annual Meeting of the Japanese Organization of Hereditary Breast and Ovarian Cancer 2022

Sakurai, Akihiro (EDT)/ Yamauchi, Hideko (EDT)/ Okamoto, Aikou (EDT)

ウェブストア価格 ¥25,172（本体¥22,884）
Springer Nature Switzerland AG（2025/05発売）
外貨定価 US$ 119.99
ポイント 228pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 69 p.
言語 ENG
商品コード 9789819643288

Full Description

This book shares cutting-edge evidence on Hereditary Breast and Ovarian Cancer (HBOC) treatment, delivering facts on breast cancer, gynecologic oncology, and basic research to contribute to clinicians' practices. It is based on the best-chosen works presented at the Japanese Organization of Hereditary Brest and Ovarian Cancer (JOHBOC) in 2022. The volume collectively provides a comprehensive view of HBOC management with the aim to contribute to the equalization and dissemination of HBOC practice as well as to serve as a foundation for future advances in the treatment of the diseases and medical practice.

While it sheds light on the present state of HBOC management in Japan, whose cases are on the increase due to partial coverage by public insurance of the HBOC diagnosis and treatment, the scope of topics covered maximizes reader insight into the latest clinical techniques, basic experimental results along with clinical controversy.

Practical Guide to Hereditary Breast and Ovarian Cancer II - Annual Meeting of JOHBOC aims to entertain a broad readership and serves as a valuable resource for professionals involved in HBOC treatment, including breast surgeons, obstetricians, gynecologists, pancreatic cancer surgeons, and urologists. The current information is crucial for informed decision-making and practice, making it beneficial for certified genetic counselors and medical staff specializing in HBOC. Additionally, it serves as an excellent reference for HBOC patients and their families.

.- RRSO and occult cancer.

.- Prostate/Pancreatic cancer in HBOC.

.- Regional collaboration for comprehensive HBOC care.

.- CRRM or Surveillance: An Evidence-Based Individual Decision-Making.

.- RRSO for aged patients with breast cancer.

.- Social Challenges of Pre-Implantation Genetic Testing for Monogenic Disorders (PGT-M) in HBOC and Medical Professional Recognition.

.- HBOC guidebook for patients and the public.

.- 2021 Annual report on the BRCA Nationwide Registry Project in the Japanese Organization of Hereditary Breast and Ovarian Cancer (JOHBOC).